Company Infant Bacterial Therapeutics AB (publ) Other OTC
Equities
Pharmaceuticals
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 12-12-31 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 22-09-18 |
Chief Operating Officer | 57 | 14-10-19 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 15-12-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 15-09-23 |
Chairman | 74 | 10-12-31 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 17-05-03 |
Director/Board Member | 63 | 18-05-14 | |
Eva Idén
BRD | Director/Board Member | 58 | 17-05-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 453,283 | 0 | 0 | 87.87 % |
Stock B | 1 | 13,018,137 | 11,837,506 ( 90.93 %) | 0 |
Company contact information
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.com![address Infant Bacterial Therapeutics AB (publ)](https://cdn.zonebourse.com/static/address/30432310.png)
Group companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+6.73% | 72.01B | |
+30.80% | 10.39B | |
+41.28% | 5.26B | |
-18.53% | 4.64B | |
+18.24% | 3.7B | |
+27.58% | 2.3B | |
-39.52% | 1.8B | |
-45.87% | 1.7B | |
-0.50% | 1.64B |